| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/04/2010 | DE102008035552A1 Substituierte Pyridine und ihre Verwendung Substituted pyridines and their use |
| 02/04/2010 | CA2732618A1 Pyrrole carboxylic acid derivatives as antibacterial agents |
| 02/04/2010 | CA2731919A1 New compounds |
| 02/04/2010 | CA2731909A1 5-alkynyl-pyrimidines |
| 02/04/2010 | CA2731358A1 5/5-or 5/6-membered condensed ring cycloalkylamine derivative |
| 02/04/2010 | CA2730770A1 Diazepan and piperazine derivatives modulators of chemokine receptors |
| 02/04/2010 | CA2729969A1 Synthesis of 3,4-diaryl-4,5-dihydro-(1h)-pyrazole-1- carboxamidine derivatives |
| 02/04/2010 | CA2729581A1 Fluorinated heteroaryls |
| 02/03/2010 | EP2149571A1 Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position |
| 02/03/2010 | EP2149561A1 Tetrahydroisoquinolin-1-one derivative or salt thereof |
| 02/03/2010 | EP2149560A1 1-substituted tetrahydroisoquinoline compound |
| 02/03/2010 | EP2149558A1 5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino-1-arylquinolin-2-ones, a process for their production and their use as anti-inflammatory agents |
| 02/03/2010 | EP2149555A1 Amine-based compound, organic light emitting device comprising the amine-based compound, and flat panel display device including the organic light emitting device |
| 02/03/2010 | EP2149552A1 5,6 substituted benzamide derivatives as modulators of EP2 receptors |
| 02/03/2010 | EP2149551A1 N-(indol-3-ylalkyl)-(hetero)arylamid derivatives as modulators of EP2 receptors |
| 02/03/2010 | EP2149550A1 Nitrogen-containing five-membered heterocyclic compound |
| 02/03/2010 | EP2148876A1 Pyrazolone derivatives as pde4 inhibitors |
| 02/03/2010 | EP2148875A1 Compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 02/03/2010 | EP2148874A1 Pyrimidine derivatives and compositions as c-kit and pdgfr kinase inhibitors |
| 02/03/2010 | EP2148873A1 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists |
| 02/03/2010 | EP2148872A1 Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists |
| 02/03/2010 | EP2148871A1 Quinoline-carboxamide derivatives as p2y12 antagonists |
| 02/03/2010 | EP2148870A1 Pyrimidinone derivatives and methods of use thereof |
| 02/03/2010 | EP2148862A1 Dihydroquinone and dihydronaphthridine inhibitors of jnk |
| 02/03/2010 | EP2148857A1 Pyrrolidine derivatives as dual nk1/nk3 receptor antagonists |
| 02/03/2010 | EP2148853A1 Insecticidal aryl pyrrolidines |
| 02/03/2010 | EP2148677A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
| 02/03/2010 | EP1963269B1 Process for amination of acrylic macromonomers and products therefrom |
| 02/03/2010 | EP1511742B1 Kinase inhibitors |
| 02/03/2010 | CN101641348A Imidazolidinone derivatives |
| 02/03/2010 | CN101641347A Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme A delta-9 desaturase |
| 02/03/2010 | CN101641346A Pyridine and pyrimidine derivatives as MGLUR2 antagonists |
| 02/03/2010 | CN101641345A Imatinib base, and imatinib mesylate and processes for preparation thereof |
| 02/03/2010 | CN100586946C Argatroban separation method |
| 02/03/2010 | CN100586945C Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 02/03/2010 | CN100586944C 2,4,5,6-substituted pyrimidines, method for the production and use thereof for preventing epiphyte |
| 02/03/2010 | CN100586927C Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 02/02/2010 | US7655804 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 02/02/2010 | US7655802 Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogs |
| 02/02/2010 | US7655798 crystallizing aripiprazole Type II from a solution of aripiprazole dissolved in a solvent selected from 2-propanol, dimethylsulfoxide or mixture and optionally further comprising ethyl acetate; solid state Type II aripiprazole without the use of a solid state heat treatment |
| 02/02/2010 | US7655797 Intermediates for making 2,4-pyrimidinediamine compounds |
| 02/02/2010 | US7655690 1-sulfonylindole derivatives, their preparation and their use as 5-HT6 ligands |
| 02/02/2010 | US7655688 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 02/02/2010 | US7655669 Pyrimidineamide derivatives and the use thereof |
| 02/02/2010 | US7655666 Substituted 1H-quinazoline-2,4-diones useful as AMPA receptor ligands |
| 02/02/2010 | US7655665 Nitromethylene derivatives and their use |
| 02/02/2010 | US7655664 Hydantoin derivatives as metalloproteinase inhibitors |
| 02/02/2010 | US7655663 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 02/02/2010 | US7655661 Prodrugs of CC-1065 analogs |
| 02/02/2010 | US7655660 Antitumor antibiotic; water solubility, stability; N-[2-{(1-chloromethyl)-1,2-dihydro-5-[(4-methylpiperazino)carbonyloxy]-3H-benz(e)indol-3-yl}carbonyl]-1H-indol-5-yl]-5-[(3-methyldithio-1-oxopropyl)-amino]-1H-indole-2-carboxamide |
| 02/02/2010 | US7655657 5-{6-[(3R)-1-azabicyclo[2.2.2]oct-3-yloxy]pyridazin-3-yl}-1-H-indole tartaric acid salt; nicotinic acetylcholine receptor modulation |
| 02/02/2010 | US7655649 Inhibitors of Akt activity |
| 02/02/2010 | US7655647 3-[(1-oxo-2-cyclopropylmethyl-heptyl)]amino-1-methyl-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one; amyloid precursor protein and beta -peptide inhibitor; beta or gamma secretases inhibitor; amyloid plaques and neurofibrillar tangles; neurodegenerative diseases: Alzheimer's disease; Down syndrome |
| 02/02/2010 | CA2541301C P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same |
| 02/02/2010 | CA2516682C Imidazol-4-yl-ethynyl-pyridine derivatives |
| 02/02/2010 | CA2485685C Calcium receptor modulating agents |
| 02/02/2010 | CA2454830C Substituted urea neuropeptide y y5 receptor antagonists |
| 02/02/2010 | CA2442478C Use of group i mglur antagonists in the treatment of fragile x syndrome, autism, mental retardation |
| 02/02/2010 | CA2418868C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 02/02/2010 | CA2407428C Hydantoin-containing glucokinase activators |
| 02/02/2010 | CA2401832C 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 02/02/2010 | CA2390858C N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor xa |
| 02/02/2010 | CA2345838C Method for the synthesis of radiolabeled compounds |
| 02/02/2010 | CA2333963C Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds |
| 02/02/2010 | CA2316172C Indole derivatives as inhibitors of factor xa |
| 02/02/2010 | CA2315205C Substituted 2-aryl-4-amino-quinazolines, methods for the prodution ans use thereof as medicaments |
| 02/02/2010 | CA2294809C Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 01/28/2010 | WO2010011868A2 Pyridine sulfonamide modulators of endothelin-a-receptor |
| 01/28/2010 | WO2010011853A2 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
| 01/28/2010 | WO2010011821A2 Dual-acting antihypertensive agents |
| 01/28/2010 | WO2010011657A1 Bicyclic heterocycle derivatives as histamine h3 receptor antagonists |
| 01/28/2010 | WO2010011653A1 Tricyclic heterocycle derivatives as histamine h3 antagonists |
| 01/28/2010 | WO2010011626A2 Pyridinyl modulators of ϒ-secretase |
| 01/28/2010 | WO2010011570A1 Adamantyl diamide derivatives and uses of same |
| 01/28/2010 | WO2010011538A1 Amidophenoxyindazoles useful as inhibitors of c-met |
| 01/28/2010 | WO2010011325A2 Synthesis and utilization of small molecules for the treatment of inflammation associated with interleukin-1 signaling |
| 01/28/2010 | WO2010011316A1 SUBSTITUTED 1,2,3,4- TETRAHYDROCYCLOPENTA[b]INDOL-3-YL) ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS |
| 01/28/2010 | WO2010010702A1 Prophylactic or therapeutic agent for axial myopia |
| 01/28/2010 | WO2010010154A1 3,4-diarylpyrazoles as protein kinase inhibitors |
| 01/28/2010 | WO2010010056A1 Process for the preparation of esomeprazole magnesium in a stable form |
| 01/28/2010 | WO2010009968A1 Insecticidal phenyl- or pyridyl-piperidine compounds |
| 01/28/2010 | WO2010009814A1 5-[ (3,3,3-trifluoro-2-hydroxy-1-arylpropyl) amino]-1-arylquinolin-2-ones, a process for their production and their use as anti-inflammatory agents |
| 01/28/2010 | WO2010009775A1 Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases |
| 01/28/2010 | WO2010009487A1 Chlorophyll catabolites |
| 01/28/2010 | WO2009145357A8 Benzo [1, 4] diazepines substituted at the 1-position by a ring, for use as antidepressants |
| 01/28/2010 | WO2009132452A8 Diaryl-cyclylalkyl derivatives as calcium channel blockers |
| 01/28/2010 | WO2009120094A3 Substituted pyrimidines and triazines and their use in cancer therapy |
| 01/28/2010 | US20100022780 Process for preparing 2-amino-5-cyanobenzoic acid derivatives |
| 01/28/2010 | US20100022779 Isotopically substituted proton pump inhibitors |
| 01/28/2010 | US20100022773 Apoptosis promoters |
| 01/28/2010 | US20100022769 Novel polynitrogenated systems as anti-hiv agents |
| 01/28/2010 | US20100022599 imidazole or triazole derivatives such as 4-[4-((R)-1-Benzyl-2-hydroxycarbamoylethylcarbamoyl)-2-butylimidazol-1-ylmethyl]benzoic acid methyl ester, used for treating congestive heart failure or as hypotensive agents |
| 01/28/2010 | US20100022598 Substituted inmidazoles as bombesin receptor subtype-3 modulators |
| 01/28/2010 | US20100022591 Piperidine gpcr agonists |
| 01/28/2010 | US20100022589 Pyridine-3-carboxamide compounds and their use for inhibiting 11-beta-hydroxysteroid dehydrogenase |
| 01/28/2010 | US20100022587 Derivatives of 2-phenyl-3-hydroxyquinoline-4(1h)-one and methods of their preparation and utilization |
| 01/28/2010 | US20100022586 Bicyclic heteroaryl inhibitors of pde4 |
| 01/28/2010 | US20100022585 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
| 01/28/2010 | US20100022583 PYRIDINYL MODULATORS OF gamma-SECRETASE |
| 01/28/2010 | US20100022581 Pyrrolidine-substituted azaindole compounds having 5-ht6 receptor affinity |